Tekla Life Sciences Inves...

NYSE: HQL · Real-Time Price · USD
13.82
0.17 (1.25%)
At close: Aug 15, 2025, 3:59 PM
13.86
0.29%
After-hours: Aug 15, 2025, 05:16 PM EDT

Tekla Life Sciences Investors Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Net Income
n/a 22.35M -104.6K 64.53K
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
n/a n/a n/a n/a
Other Non-Cash Items
n/a -22.35M 104.6K -64.53K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
n/a n/a n/a n/a
Operating Cash Flow
n/a n/a n/a -0.74
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a
Financial Cash Flow
n/a n/a n/a n/a
Net Cash Flow
n/a 32.00 -545 -0.74
Free Cash Flow
n/a n/a n/a -0.74